IPD Products1

Founded in February 2020, IPD Products has designed an air sterilization product – the Ionic Plague Destroyer – that is engineered to remove pathogens from the air and create healthy, safe, and clean indoor environments. While the company was formed less than six months ago, it has secured a licensing agreement for a patent that covers methods for air disinfection and sterilization.

Looking ahead, IPD Products hopes its product will serve as an important tool to help combat transmission of the novel coronavirus indoors. The company is raising its first round of capital to ramp up manufacturing and production in anticipation of a launch in Q4.

Investors that purchase the first 350,000 Crowd Notes, and thereby fund the first $350,000, will receive Crowd Notes with a conversion provision based on a $3.5 million valuation cap instead of a $5 million valuation cap. That means, in connection with equity financing of at least $1 million, the company has the option to convert the Crowd Note into non-voting preferred shares (Conversion Shares) at a price based on the lower of (A) a 20% discount to the price per share paid for Preferred Shares by investors in the Qualified Equity Financing or (B) the price per share based on a $3.5 million valuation cap (instead of $5 million).

Plans to launch the Ionic Plague Destroyer in Q4 2020, an air sterilizer designed to combat airborne pathogens, such as SARS-CoV-2, the virus responsible for COVID-19, in indoor environments
Licensed patent from Drexel University that covers methods for air disinfection and sterilization
Founding team has extensive experience commercializing technology for organizations like Pfizer and Bristol Myers Squibb, as well as building out robust patent portfoliosi ii
In 2021, the company hopes to expand its product line to include integrations with HVAC systems and PPE

• Intermediary Fees (5%)
• Product Development (23%)
• General Working Capital (72%)

Howard Nelson - President
Howard has spent his career specializing in commercializing new products and new technologies in the healthcare, software, and chemical processes industries. Howard has previous high-level experience at startups, including founding Origin, LDS Technology Consultants, and Red Shift Energy, as well as large corporation experience like Bristol-Myers Squibb, Honeywell, and Pfizer. Howard earned his MBA from Tulane University and his BA from Princeton University in Economics.

C. Eric Anthony, JD - Counsel and Head of Human Resources
Eric has extensive experience as a founder and attorney. Eric was a co-founder at three organizations; LDS Technology Consultants, Red Shift Energy, and Origin. Additionally, he has owned and operated his own legal practice for 23 years where he advises and consults business on their formation and operation. Eric earned a BS in accounting from Southwest Texas State University in 1993 and a Juris Doctorate from St. Mary’s University in 1996. He was admitted to the State Bar of Texas in 1996.

Alexander Gutsol, PhD - Chief Science Officer
Alexander is the inventor of the patent that IPD Products is licensing from Drexel University, and he serves as the science lead at the company. He is the co-founder of the Drexel Plasma Research Institute and an inventor to dozens of patents.xxix Additionally, Alexander previously spent nearly a decade as a technical lead and principal scientist at Chevron. He earned his PhD in Physics and Mathematics from the Moscow Institute of Physics and Technology.

Sharon R. Naismith - Chief Financial Officer
Sherry has a wealth of experience in financial systems, public account, audit, and regulatory filings. She has worked for the regional accounting firm King, Griffin and Adamson, and before that with Coopers and Lybrand. Sherry has a BBA from Texas A&M Mays Business School and earned her CPA in 1993.

Discount: 20%